Delivery and Execution
Our development approach allows us to get drugs to patients sooner
Drug Development Roadmap
Our experienced team understands the interdependencies that create efficiencies in clinical development and uses this knowledge to drive improved outcomes
Novel trial design using Bayesian thinking and sequential learning, drives improved results
Trial Design
OMIC Analysis
Appropriate scientific analyses to evidence tumour type selection
Patient
Stratification
Ensuring the right patients are always recruited to the right trials
Clinical Trial
Lifecycle
Management
Appropriate additional tumour types investigated, creating incremental asset value
Legal & IP
Legal patent maintenance and new IP filing capturing future value for out-license partners
CMC
Clinical and pre-clinical processes: chemistry, manufacturing and control done early in process
Commercial
Deep analytics driven approach to understand market, pricing and competitive landscape
IT
Reliability and robustness of electronic submissions and filings
Regulatory
Managing interactions and ensuring efficient approvals
Out-License
Royalty agreements with larger pharmaceutical companies for marketing and distribution
A Patient focused trial design process based on our deep understanding of how the drug can commercially make it to market
Optimising the way we deliver projects through our functional service provider model
Our dedicated and experienced in-house team facilitates the interface with functional providers to scale our operations, drive efficiency, problem solving and patient advocacy whilst overseeing the entirety of the development process, through to out-license
Speak to us about being a service provider